Risk of Severe Breakthrough COVID-19 Is Low Among Vaccinated Individuals with HIV
Pharmacy Times
NOVEMBER 26, 2022
Study results show that patients with moderate or severe immune suppression should be considered a priority for additional vaccine doses and risk-reduction strategies.
Let's personalize your content